Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial

OBJECTIVES: To assess the efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndrome (ACS) presenting during off- and on-hours. BACKGROUND: The efficacy and safety of ticagrelor versus prasugrel in patients with ACS according to time of hospital presentation remain u...

Descripción completa

Detalles Bibliográficos
Autores principales: Behnes, Michael, Lahu, Shqipdona, Ndrepepa, Gjin, Menichelli, Maurizio, Mayer, Katharina, Wöhrle, Jochen, Bernlochner, Isabell, Gewalt, Senta, Witzenbichler, Bernhard, Hochholzer, Willibald, Sibbing, Dirk, Cassese, Salvatore, Angiolillo, Dominick J., Hemetsberger, Rayyan, Valina, Christian, Müller, Arne, Kufner, Sebastian, Hamm, Christian W., Xhepa, Erion, Hapfelmeier, Alexander, Sager, Hendrik B., Joner, Michael, Fusaro, Massimiliano, Richardt, Gert, Laugwitz, Karl-Ludwig, Neumann, Franz-Josef, Schunkert, Heribert, Schüpke, Stefanie, Kastrati, Adnan, Akin, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050020/
https://www.ncbi.nlm.nih.gov/pubmed/35789430
http://dx.doi.org/10.1007/s00392-022-02040-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050020/
https://www.ncbi.nlm.nih.gov/pubmed/35789430
http://dx.doi.org/10.1007/s00392-022-02040-z

Ejemplares similares